Hanoi (VNA) – As many as 554 volunteersjoining the second-stage human trials of home-grown Nano Covax COVID-19 vaccinegot the second shots over the past 14 days.
Associate Prf., Dr. Chu Van Men, Director of theMilitary Medical University’s Centre for Clinical Trials and Bioequivalence,said on April 8 that among the volunteers, 278 received the jabs from theuniversity, while 276 others in Ben Luc district, the Mekong Delta province ofLong An, were vaccinated by HCM City-based Pasteur Institute.
🏅 After the injection, the volunteers exhibitedsymptoms such as light fever, injection site pain, muscle aches, joint pain andfatigue, which did not require medical intervention. They are now in stableconditions.
A preliminary report on testing results is scheduledto be issued this May.
The third phase of human trials is expected to cover10,000 – 15,000 people in both Vietnam and other countries.
The first-stage trials of Nano Covax showed that thevaccinated volunteers have had antibodies against the UK variant (B117). Phase2 focuses on seeking antibodies against the UK and South Africa variants,according to Men.
Navo Covax, developed by the Nanogen PharmaceuticalBiotechnology JSC, is the first COVID-19 vaccine of Vietnam to be tested inclinical trials.
The country also has other COVID-19 candidatevaccines under development: IVAC from the Institute of Vaccines and MedicalBiologicals, VABIOTECH from the Company for Vaccine and Biological ProductionNo 1, and POLYVAC from the Centre for Research and Production of Vaccines andBiologicals.
🐼 Vietnam expects to have the first batch oflocally-produced COVID-19 vaccines at the end of the third quarter of 2021./.
The Military Medical University under the Ministry of National Defence on March 25 began giving the second shots of the Nano Covax COVID-19 vaccine in the second trial phase to 26 volunteers who receive the first jabs between February 26 and March 10.
Deputy Prime Minister Vu Duc Dam and Deputy Minister of Science and Technology Pham Cong Tac on March 26 received the jabs of Vietnamese-made COVID-19 vaccine, Nano Covax, as part of the second phase of human trials.
The time for research and production of Nano Covax, Vietnam’s first candidate vaccine to reach human trial stage, has been shortened as much as possible, but safety has been ensured. Prof, Dr. Do Quyet, Director of the Hanoi-based Vietnam Military Medical University made the remarks on March 26 when the second shots of Nano Covax COVID-19 vaccine were given to volunteers.
Two COVID-19 vaccines Nano Covax and Covivac, which were studied and developed in Vietnam, have proved to be safe and effective in the first and second clinical trials.
Despite storm-related disruptions and flight delays, the organs were successfully transported via a combination of air and ground travel. All patients are currently stable and recovering well.
The patient, Tieu Viet But, born in 1970 and residing in Binh Tri commune, Binh Son district, the central province of Quang Ngai, was working aboard fishing vessel Qng – 95657TS when the incident occurred at 7:00 am.
All drugs entering hospitals must have a clear origin, so counterfeit drugs are only in the market, not in hospital, affirmed Minister of Health Dao Hong Lan.
To achieve its goal of becoming a developed nation by 2045, Vietnam is prioritising the integration of AI and digital tools into the training of future doctors, said Assoc. Prof. Dr. Nguyen Viet Nhung, Dean of Medicine at University of Medicine and Pharmacy, Vietnam National University (VNU) Hanoi.
Health experts called for collective disease prevention and integrated solutions to achieve zero dengue deaths in the country at an online talk show on June 14.
The PM called for closer, broader, and more effective cooperation with Vietnamese partners, guided by the principles of mutual benefit, joint efforts, shared outcomes, and common development, including promoting stronger public-private partnerships and collaboration with businesses.
Renowned for its expertise in complex surgeries, the hospital has attracted foreign patients seeking treatment for conditions such as kidney and urinary tract stones, urological and gastrointestinal cancers, and male reproductive disorders. Most procedures are performed using advanced techniques, including laparoscopy and robotic surgery. T
Leading Vietnamese companies specialising in respiratory and dermatological treatments, traditional medicine, immune support supplements, and functional foods will have an opportunity to connect with international distributors and secure export deals.
The project aimed to enable early detection and reduce the risk of dangerous complications, targeting patients with chronic diabetes, cardiovascular conditions and metabolic disorders.
A 2023 report by the Vietnam Health Economics Association estimated that the total cost of tobacco-related healthcare and economic losses reached 108 trillion VND (4.14 billion USD) annually – equivalent to 1.14% of GDP and five times higher than the budget revenue generated by the tobacco industry.
All eligible patients will receive surgical interventions and post-operative care in accordance with Vietnamese medical standards and global care protocols.
Medical screenings and surgical interventions for children with disabilities are being carried out at health centers across Dien Bien. So far this year, 242 children have been identified for diagnosis, treatment, surgery, and the provision of assistive devices.
The Red Journey has become the country’s largest and most effective blood donation campaign, leaving a strong impression on the national voluntary blood donation movement.
This case marks the ninth fetal cardiac intervention conducted in HCM City, and it was considered the most technically demanding to date due to the fetus’s extremely early gestational age and the severity of the condition as diagnosed with aortic atresia.
The groundbreaking ceremony took place one day after the VNVC Vaccine JS Company and Sanofi Group exchanged cooperation documents on vaccine production technology transfer under the witness of State President Luong Cuong and French President Emmanuel Macron.
Vietnam’s traditional medicine took centre stage at the International Congress Biopharm Nonclinical Development, BioNCiD 2025, held on May 25-26 in the Cuban city of Varadero, amid growing global interest in sustainable healthcare solutions.
Under the agreement, VNVC and Sanofi will gradually implement technology transfers to enable domestic production of several key Sanofi vaccines that are widely used in Vietnam. In addition, Sanofi will support VNVC in training human resources and quality management in vaccine research and manufacturing.
Despite the ongoing global circulation and unpredictable developments of SARS-CoV-2, the World Health Organisation (WHO) hasn’t issued new warnings about COVID-19, said the Ministry of Health.
Nano Covax COVID-19 vaccine (Photo: vneconomy.vn) 
